Gan Jasmine Ming, Boucher Emily Louise, Lovett Nicola Georgia, Roche Sophie, Smith Sarah Catherine, Pendlebury Sarah Tamsin
Wolfson Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Departments of Acute General Internal Medicine and Geratology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Lancet Healthy Longev. 2025 Jul;6(7):100731. doi: 10.1016/j.lanhl.2025.100731.
Reliable estimates of delirium occurrence and outcomes are necessary to inform hospital services, research, and policy, but inclusive cohorts with long-term follow-up are scarce. We aimed to assess the age-specific occurrence of delirium in acute general (internal) medicine, associated factors, and 10-year outcomes stratified by age and comorbid dementia status.
This longitudinal, observational study was done at the John Radcliffe Hospital (Oxford, UK). We included consecutive adult patients aged 16 years and older in an acute general (internal) medicine service over six 8-week periods (between Sept 4, 2010, and Nov 15, 2018). Delirium was diagnosed prospectively using the Confusion Assessment Method and Diagnostic and Statistical Manual of Mental Disorders, fourth edition, criteria and subcategorised as prevalent (≤48 h of admission) or incident (>48 h postadmission). Odds ratios adjusted (ORs) for demographics, comorbidity, frailty, and illness severity were calculated for binarised outcomes and adjusted hazard ratios (HRs) were calculated for time to death.
1846 patients were admitted to acute general (internal) medicine (mean age 68·2 years [SD 20·0], age range 16-102 years), 426 (23% [95% CI 21-25]) of whom had delirium (prevalent n=290 [68%], incident n=73 [17%], both prevalent and incident n=63 [15%]), of whom 134 (31·5%) had dementia. 950 (51·5%) patients were female, 895 (48·5%) were male, and sex data were missing for one patient. Delirium increased with age, from six (2% [95% CI 1-4]) of 340 patients younger than 50 years and 31 (9% [6-13]) of 333 patients at age 50-64 years to 57 (20% [16-25]) of 281 at age 65-74 years, 245 (35% [31-38]) of 704 at age 75-89 years, and 87 (46% [39-54]) of 188 at age 90 years and older. Of the 37 patients younger than 65 years who had delirium, 28 (76%) had an underlying neurological or neuropsychiatric disorder. In those aged 65 years or older, delirium was overall associated (all p<0·001, age and sex adjusted) with dementia (OR 3·63 [95% CI 2·65-4·98]), pre-admission dependency (2·63 [2·02-3·43]), comorbidity burden (1·04 [1·02-1·05]), and frailty (moderate vs low risk 3·62 [2·70-4·85] and high vs low risk 11·85 [7·24-19·42]), with stronger associations in patients without comorbid dementia than in those with comorbid dementia. Delirium predicted inpatient stay longer than 7 days (OR 2·48 [1·84-3·35]), discharge care needs (2·41 [1·70-3·40]), and mortality during admission (2·45 [1·52-3·94]). The increased risk of death in the delirium group was highest in the immediate postadmission period and attenuated thereafter, but was maintained for up to 10 years of follow-up (HR 2·03 [95% CI 1·40-2·97] for 30-day mortality vs 1·52 [1·30-1·77] for 10-year mortality). Excess inpatient mortality was highest in younger age groups versus older age groups (OR 4·38 [95% CI 1·18-16·31]; p=0·028 at age 65-74 years vs 1·96 [1·02-3·75]; p=0·043 at age 75-89 years and 2·86 [1·14-7·16]; p=0·025 at age 90 years or older) and in those without versus with comorbid dementia (OR 3·02 [1·73-5·25]; p<0·001 vs 1·47 [0·58-3·75]; p=0·42).
Our findings support current guidelines for routine on-admission delirium screening from age 65 years. Delirium outcomes are relatively more adverse in those aged 65-74 years without comorbid dementia in whom interventions and clinical trials should be prioritised.
National Institute for Health and Care Research and the Medical Research Council.
准确估计谵妄的发生率和预后对于指导医院服务、研究及政策制定至关重要,但包含长期随访的全面队列研究较为匮乏。我们旨在评估急性普通(内科)医学中不同年龄段谵妄的发生率、相关因素以及按年龄和共病痴呆状态分层的10年预后情况。
这项纵向观察性研究在约翰·拉德克利夫医院(英国牛津)开展。我们纳入了在六个为期8周的时间段(2010年9月4日至2018年11月15日)期间连续入住急性普通(内科)医学科室的16岁及以上成年患者。谵妄采用《精神障碍诊断与统计手册》第四版标准及意识错乱评估法进行前瞻性诊断,并分为入院时存在(≤48小时)或入院后发生(>48小时)。针对二元结局计算人口统计学、共病、虚弱及疾病严重程度的调整比值比(OR),针对死亡时间计算调整风险比(HR)。
1846例患者入住急性普通(内科)医学科室(平均年龄68.2岁[标准差20.0],年龄范围16 - 102岁),其中426例(23%[95%置信区间21 - 25])发生谵妄(入院时存在290例[68%],入院后发生73例[17%],入院时存在且入院后发生63例[15%]),其中134例(31.5%)患有痴呆。950例(51.5%)患者为女性,895例(48.5%)为男性,1例患者性别数据缺失。谵妄发生率随年龄增长而升高,50岁以下340例患者中有6例(2%[95%置信区间1 - 4]),50 - 64岁333例患者中有31例(9%[6 - 13]),65 - 74岁281例患者中有57例(20%[16 - 25]),75 - 89岁704例患者中有245例(35%[31 - 38]),90岁及以上188例患者中有87例(46%[39 - 54])。在65岁以下发生谵妄的37例患者中,28例(76%)存在潜在神经或神经精神疾病。在65岁及以上患者中,谵妄总体与痴呆(校正年龄和性别后所有p<0.001,OR 3.63[95%置信区间2.65 - 4.98])、入院前依赖(2.63[2.02 - 3.43])、共病负担(1.04[1.0,2 - 1.05])及虚弱(中度与低风险3.62[2.70 - 4.85],高度与低风险11.85[7.24 - 19.42])相关,在无共病痴呆患者中的关联比有共病痴呆患者更强。谵妄预示住院时间超过7天(OR 2.48[1.84 - 3.35])、出院后护理需求(2.41[1.70 - 3.40])及住院期间死亡率(2.45[1.52 - 3.94])。谵妄组死亡风险增加在入院后即刻最高,随后减弱,但在长达10年的随访中仍持续存在(30天死亡率HR 2.03[95%置信区间1,40 - 2.97],10年死亡率HR 1.52[1.30 - 1.77])。年轻年龄组与老年年龄组相比,住院额外死亡率更高(65 - 74岁OR 4.38[95%置信区间1.18 - 16.31];p = 0.028,75 - 89岁OR 1.96[1.02 - 3.75];p = 0.043,90岁及以上OR 2.86[1.14 - 7.16];p = 0.025),无共病痴呆患者与有共病痴呆患者相比也更高(OR 3.02[1.73 - 5.25];p<0.001,OR 1.47[0.58 - 3.75];p = 0.42)。
我们的研究结果支持当前从65岁起进行入院常规谵妄筛查的指南。在65 - 74岁无共病痴呆患者中,谵妄预后相对更差应优先进行干预及临床试验。
国家卫生与保健研究所及医学研究理事会。